Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Xianhai Mao"'
Autor:
Qi Li, Chen Chen, Jingbo Su, Yinghe Qiu, Hong Wu, Tianqiang Song, Xianhai Mao, Yu He, Zhangjun Cheng, Jingdong Li, Wenlong Zhai, Dong Zhang, Zhimin Geng, Zhaohui Tang
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract Objective We aimed to evaluate the prognosis and adjuvant chemotherapy (ACT) in intrahepatic cholangiocarcinoma (ICC) patients with different etiology after radical resection. Methods A total of 448 patients with ICC who underwent radical re
Externí odkaz:
https://doaj.org/article/b783c096e595400b92111b06abad2887
Autor:
Qi Li, Jian Zhang, Chen Chen, Tianqiang Song, Yinghe Qiu, Xianhai Mao, Hong Wu, Yu He, Zhangjun Cheng, Wenlong Zhai, Jingdong Li, Dong Zhang, Zhimin Geng, Zhaohui Tang
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundThe influence of different postoperative recurrence times on the efficacy of adjuvant chemotherapy (ACT) for intrahepatic cholangiocarcinoma (ICC) remains unclear. This study aimed to investigate the independent risk factors and establish a
Externí odkaz:
https://doaj.org/article/674a3672247347c381f6cc8162fb64bf
Autor:
Qi Li, Chen Chen, Jian Zhang, Hong Wu, Yinghe Qiu, Tianqiang Song, Xianhai Mao, Yu He, Zhangjun Cheng, Wenlong Zhai, Jingdong Li, Dong Zhang, Zhimin Geng, Zhaohui Tang
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundThe preoperative nutritional status and the immunological status have been reported to be independent prognostic factors of patients with intrahepatic cholangiocarcinoma (ICC). This study aimed to investigate whether prognostic nutritional
Externí odkaz:
https://doaj.org/article/c687e21d3f77480ca7ba86e42ac820be
Autor:
Qiulong Yan, Siyi Zhang, Shenghui Li, Guangyang Wang, Aiqin Zhang, Taiyang Jin, Yue Zhang, Qingbo Lv, Manchun Xiao, Yuanyuan Sun, Xiang Li, Song Cui, Rui Li, Xiaochi Ma, Chao Wang, Xiangge Tian, Xiaohui Duan, Yi Xin, Xianhai Mao, Yufang Ma
Publikováno v:
Frontiers in Microbiology, Vol 12 (2021)
The microbes in human bile are closely related to gallbladder health and other potential disorders. Although the bile microbial community has been investigated by recent studies using amplicon or metagenomic sequencing technologies, the genomic infor
Externí odkaz:
https://doaj.org/article/866edfc2aa9a4389bc4a9f21b7b3f2aa
Autor:
Sulai Liu, Honglian Zou, Yonggang Wang, Xiaohui Duan, Chen Chen, Wei Cheng, Le Wang, Ning Ning, Hongying Tang, Meifu Chen, Xianhai Mao, Chuang Peng, Hao Li, Yu Jiang, Bo Jiang
Publikováno v:
Cellular Physiology and Biochemistry, Vol 51, Iss 4, Pp 1584-1599 (2018)
Background/Aims: Acute pancreatitis contributes to high mortality in pancreatitis patients, and miRNAs play a vital role in the development of acute pancreatitis (AP), however, its precise biological role remains largely elusive. Methods: To clarify
Externí odkaz:
https://doaj.org/article/cd11c58499694679bfc1412698801962
Autor:
Qunfang Zhou, Xiaohui Wang, Ruixia Li, Chenmeng Wang, Juncheng Wang, Xiaoyan Xie, Yali Li, Shaoqiang Li, Xianhai Mao, Ping Liang
Publikováno v:
Journal of Gastroenterology. 57:684-694
Background Radiofrequency ablation (RFA) is considered as a convenient treatment with mild damage in treating recurrent hepatocellular carcinoma (RHCC). However, for patients with high risk of progression after RFA still needs new strategies to decre
Autor:
Quanren Wang, Shuni Wang, Xiao Zhang, Guowen Yin, Enxiao Li, Zujiang Yu, Xinmin Zhou, Kuansheng Ma, Zhanyu Pan, Xi Chen, Kangsheng Gu, Zhiming Wang, Xiaoming Chen, Lequn Li, Jiayin Yang, Ling Zhang, Xianhai Mao, Jianping Xiong, Zhenggang Ren, Jingfeng Liu, Tao Yin, Li Xu, Yanqiao Zhang, Guoliang Shao, Jian Wu, Lihua Wu, Yun Zhang, Shanzhi Gu, Jie Shen, Jianming Xu
Purpose:We assessed the efficacy and safety of camrelizumab [an anti-programmed death (PD-1) mAb] plus apatinib (a VEGFR-2 tyrosine kinase inhibitor) in patients with advanced hepatocellular carcinoma (HCC).Patients and Methods:This nonrandomized, op
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c896809f821cea052765763557d4de46
https://doi.org/10.1158/1078-0432.c.6530222.v1
https://doi.org/10.1158/1078-0432.c.6530222.v1
Autor:
Quanren Wang, Shuni Wang, Xiao Zhang, Guowen Yin, Enxiao Li, Zujiang Yu, Xinmin Zhou, Kuansheng Ma, Zhanyu Pan, Xi Chen, Kangsheng Gu, Zhiming Wang, Xiaoming Chen, Lequn Li, Jiayin Yang, Ling Zhang, Xianhai Mao, Jianping Xiong, Zhenggang Ren, Jingfeng Liu, Tao Yin, Li Xu, Yanqiao Zhang, Guoliang Shao, Jian Wu, Lihua Wu, Yun Zhang, Shanzhi Gu, Jie Shen, Jianming Xu
Supplementary Methods, Supplementary Figure S1-4, Supplementary Table S1-8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd5ad80e3eb618e473ad306b9053d36c
https://doi.org/10.1158/1078-0432.22479434
https://doi.org/10.1158/1078-0432.22479434
Publikováno v:
Aging (Albany NY)
Cholangiocarcinoma (CCA) has been well known as the second most common primary tumor of hepatobiliary system. PSMC2 (proteasome 26S subunit ATPase 2) is a key member of the 19S regulatory subunit of 26S proteasome, responsible for catalyzing the unfo
Autor:
Xianhai Mao, Sulai Liu, Yu Jiang, Chuang Peng, Zhangtao Yu, Nanhui Yu, Le Wang, Bo Jiang, Mengting Cai, Zhihua Zhang, Yinghui Song, Xiehong Liu, Lianhong Zou
Publikováno v:
Aging (Albany NY)
Background Protein phosphatase magnesium-dependent 1 delta (PPM1D), also referred to as wild-type p53-induced phosphatase 1 (Wip1) or protein phosphatase 2C delta (PP2Cδ), is an oncogenic nuclear serine/threonine phosphatase belonging to the PP2C fa